"The history of psychiatry is a history of fads in theory, diagnosis, and treatment. Such rapid shifts in conceptualization such as the emergence of the concept of adult ADHD almost always warrant informed critical examination."
Total 2Q 2023 product revenue of $46.7 million Auvelity® 2Q 2023 net product sales of $27.6 million, representing 76% quarter-over-quarter growth Sunosi® 2Q 2023 net product.
NEW YORK, July 07, 2023 (GLOBE NEWSWIRE) Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company developing and delivering novel therapies for the management of central nervous system (CNS) disorders,